The Journal of Immunology, Vol 155, Issue 5 2339-2349, Copyright © 1995 by American Association of Immunologists

ARTICLES

Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity

WR Heath, F Karamalis, J Donoghue and JF Miller
Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.

RIP-Kb mice, which express H-2Kb (Kb) molecules on their pancreatic beta cells, were used to examine the requirements for induction of autoimmune diabetes caused by CD8+ T cells. Previous studies showed that when these mice were crossed to mice expressing a Kb-specific TCR transgene, those CD8+ cells expressing the highest density of the transgenic TCR (presumably the highest avidity cells) were deleted intrathymically due to aberrant expression of Kb at this site. The remaining low avidity cells ignored Kb-bearing beta cells, even after priming, but were able to cause autoimmune diabetes when supplied with Il-2. To examine the properties of high avidity autoreactive CD8+ T cells, the thymic compartment of RIP-Kb mice was replaced with normal tissue to enable the maturation of CD8+ cells expressing the highest density of the transgenic TCR. These high avidity cells generally ignored Kb-expressing beta cells, but became autoaggressive after priming. Importantly, analysis of islet infiltration by CD8+ T cells revealed the presence of infiltrating cells in all mice examined within 3 wk of priming, but such infiltration was not usually apparent at later time points. In some cases, multiple primings were necessary for full development of autoimmunity. This implied that beta cells could act as transient targets for CD8+ T cell attack but could not sustain the stimulation of primed CD8+ cells. These studies indicate that the duration of priming stimulus and the avidity of the autoreactive CD8+ cells profoundly influence the severity of autoimmune disease.

This article has been cited by other articles:

				O. A. Elisseeva, Y. Oka, A. Tsuboi, K. Ogata, F. Wu, E. H. Kim, T. Soma, H. Tamaki, M. Kawakami, Y. Oji, et al. Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies Blood, May 1, 2002; 99(9): 3272 - 3279. [Abstract] [Full Text] [PDF]

				D. Voehringer, C. Blaser, A. B. Grawitz, F. V. Chisari, K. Buerki, and H. Pircher Break of T Cell Ignorance to a Viral Antigen in the Liver Induces Hepatitis J. Immunol., September 1, 2000; 165(5): 2415 - 2422. [Abstract] [Full Text] [PDF]

				Y. Oka, K. Udaka, A. Tsuboi, O. A. Elisseeva, H. Ogawa, K. Aozasa, T. Kishimoto, and H. Sugiyama Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product J. Immunol., February 15, 2000; 164(4): 1873 - 1880. [Abstract] [Full Text] [PDF]

				C. Kurts, R. M. Sutherland, G. Davey, M. Li, A. M. Lew, E. Blanas, F. R. Carbone, J. F. A. P. Miller, and W. R. Heath CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose PNAS, October 26, 1999; 96(22): 12703 - 12707. [Abstract] [Full Text] [PDF]

				T. Doan, K. Herd, M. Street, G. Bryson, G. Fernando, P. Lambert, and R. Tindle Human Papillomavirus Type 16 E7 Oncoprotein Expressed in Peripheral Epithelium Tolerizes E7-Directed Cytotoxic T-Lymphocyte Precursors Restricted through Human (and Mouse) Major Histocompatibility Complex Class I Alleles J. Virol., July 1, 1999; 73(7): 6166 - 6170. [Abstract] [Full Text]

				J. Verdaguer2, A. Amrani2, B. Anderson, D. Schmidt, and P. Santamaria Two Mechanisms for the Non-MHC-Linked Resistance to Spontaneous Autoimmunity J. Immunol., April 15, 1999; 162(8): 4614 - 4626. [Abstract] [Full Text] [PDF]

				P. M. Dubois, M. Pihlgren, M. Tomkowiak, M. Van Mechelen, and J. Marvel Tolerant CD8 T Cells Induced by Multiple Injections of Peptide Antigen Show Impaired TCR Signaling and Altered Proliferative Responses In Vitro and In Vivo J. Immunol., November 15, 1998; 161(10): 5260 - 5267. [Abstract] [Full Text] [PDF]

				I. Caminschi, E. Venetsanakos, C. C. Leong, M. J. Garlepp, B. Scott, and B. W. S. Robinson Interleukin-12 Induces an Effective Antitumor Response in Malignant Mesothelioma Am. J. Respir. Cell Mol. Biol., November 1, 1998; 19(5): 738 - 746. [Abstract] [Full Text]

				C. Kurts, J. F.A.P. Miller, R. M. Subramaniam, F. R. Carbone, and W. R. Heath Major Histocompatibility Complex Class I-restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction J. Exp. Med., July 20, 1998; 188(2): 409 - 414. [Abstract] [Full Text] [PDF]

				W. R. Heath, C. Kurts, J. F.A.P. Miller, and F. R. Carbone Cross-tolerance: A Pathway for Inducing Tolerance to Peripheral Tissue Antigens J. Exp. Med., May 18, 1998; 187(10): 1549 - 1553. [Full Text] [PDF]

				C. Kurts, H. Kosaka, F. R. Carbone, J. F.A.P. Miller, and W. R. Heath Class I-restricted Cross-Presentation of Exogenous Self-Antigens Leads to Deletion of Autoreactive CD8+ T Cells J. Exp. Med., July 21, 1997; 186(2): 239 - 245. [Abstract] [Full Text] [PDF]

				E. Blanas, F. R. Carbone, J. Allison, J. F. A. P. Miller, and W. R. Heath Induction of Autoimmune Diabetes by Oral Administration of Autoantigen Science, December 6, 1996; 274(5293): 1707 - 11709. [Abstract] [Full Text]